Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children

Bone Marrow Transplantation

Volumn 44, Issue 12, 2009, Pages 793-797

  Lee, J W ^a   Kang, H J ^a   Kim, E K ^a   Kim, H ^a   Shin, H Y ^a   Ahn, H S ^a  

^a Seoul National University   (South Korea)

Author keywords

Hematopoietic SCT; Iron overload; Ironchelating therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BILIRUBIN; CYCLOSPORIN A; DEFERASIROX; DEFEROXAMINE MESYLATE; DEFIBROTIDE; EGLANDIN; FERRITIN; METHOTREXATE; MYCOPHENOLIC ACID; NADROPARIN; PREDNISOLONE; PROSTAGLANDIN E1; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTEREMIA; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HYPERBILIRUBINEMIA; IRON CHELATION; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOMONOCYTIC LEUKEMIA; NEUROBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPTIC SHOCK; TREATMENT OUTCOME; VEIN OCCLUSION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FERRITINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 75049086008     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.88     Document Type: Article

References (15)

1. Durken M, Nielsen P, Knobel S, Finckh B, Herrnring C, Dresow B et al. Nontransferrin-bound iron in serum of patients receiving bone marrow transplants. Free Radic Bio Med 1997; 22: 1159-1163.
2. Evens AM, Mehta J, Gordon LI. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone marrow transplant 2004; 34: 561-571.
3. Morado M, Ojeda E, Garcia-Bustos J, Aguado MJ, Arrieta R, Quevedo E et al. BMT: Serum ferritin as risk factor for veno-occlusive disease of the liver: prospective cohort study. Hematology 2000; 4: 505-512.
4. Altes A, Remacha AF, Sarda P, Baiget M, Sureda A, Martino R et al. Early clinical impact of iron overload in stem cell transplantation. A prospective study. Ann Hematol 2007; 86: 443-447.
5. Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone marrow transplant 2004; 34: 505-509.
6. Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F et al. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone marrow transplant 2006; 37: 857-864.
7. Altes A, Remacha AF, Sureda A, Martino R, Briones J, Canals C et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone marrow transplant 2002; 29: 987-989.
8. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586-4588.
9. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783.
10. Kang HJ, Kho SH, Jang MK, Lee SH, Shin HY, Ahn HS. Early engraftment kinetics of two units cord blood transplantation. Bone marrow transplant 2006; 38: 197-201.
11. Kang HJ, Shin HY, Choi HS, Ahn HS. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone marrow transplant 2004; 34: 939-943.
12. Maggio A. Light and shadows in the iron chelation treatment of haematological diseases. Br J haematol 2007; 138: 407-421.
13. Giardini C, Galimberti M, Lucarelli G, Polchi P, Angelucci E, Baronciani D et al. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia. Br J haematol 1995; 89: 868-873.
14. Gaziev D, Giardini C, Angelucci E, Polchi P, Galimberti M, Baronciani D et al. Intravenous chelation therapy during transplantation for thalassemia. Haematologica 1995; 80: 300-304.
15. Ho GT, Parker A, MacKenzie JF, Morris AJ, Stanley AJ. Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 2004; 16: 157-162.